Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin versus cisplatin-based induction plus lobaplatin versus cisplatin chemoradiotherapy for locally advanced nasopharyngeal carcinoma
ChiCTR-IIR-17013112Phase 2Not yet recruiting
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Nov 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in nasopharyngeal carcinoma (NPC) comparing Lobaplatin arm, Cisplatin + docetaxel induction followed by lobaplatin arm and Cisplatin concurrent chemoradiotherapy arm (3 arms). Primary endpoint: objective response rate. Planned start Nov 2017; status: not yet recruiting.
02
Drugs
lobaplatincisplatindocetaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-IIR-17013112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013112.